Digital medicines and digital therapeutics (DTx) are changing the future of healthcare by empowering patients to participate in—and influence—their treatment, health, and well-being. These technologies can support various stages of the healthcare journey, addressing unmet needs and bridging gaps in the market for traditional medicine. This convergence of software and healthcare creates opportunities, but the task of developing digital medicines and DTx comes with unique challenges arising from an evolving regulatory and reimbursement landscape.
Successfully developing and commercializing digital medicines and DTx require careful planning. Read our checklist to learn five key steps to ensuring that regulatory requirements and commercial goals are integrated into a cohesive go-to-market strategy that addresses barriers to uptake and drives adoption.